SWS Partners’s Radius Health, Inc. RDUS Stock Holding History

SWS Partners’s Portfolio RDUS Stock Details RDUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-935	Closed	-$30K	–	420
2017 Q4	$30K	Buy	+935	New	+$29.3K	0.02%	192

Other funds holding RDUS

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SWS Partners's RDUS Position: Q1 2018 in Review

SWS Partners sold out of Radius Health, Inc. (RDUS) in Q1 2018, closing a stake of 935 shares — an estimated $30K sold.

SWS Partners first reported a position in RDUS in Q4 2017 and held it in 1 quarter. The position peaked at $30K in Q4 2017. 138 funds tracked by Wall St. Rank hold RDUS as of Q1 2018.

SWS Partners reported no remaining Radius Health, Inc. position as of Q1 2018 after selling out during the quarter.
SWS Partners sold 935 Radius Health, Inc. shares in Q1 2018, an estimated $30K.
SWS Partners first reported a position in Radius Health, Inc. in Q4 2017 and held it in 1 quarter.
SWS Partners's Radius Health, Inc. position peaked at $30K in Q4 2017.
138 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q1 2018.

Based on SWS Partners's 13F filing for Q1 2018, filed 15 May 2018.